Arca
Skip to content
Tools
Tools

Dry eye syndrome

Drug research and approvals for dry eye syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 145 studies of dry eye syndrome are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 145
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 145 recruiting on ClinicalTrials.gov ↗

How its trials ended

1,116 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 199 whose ending is known, 62% met their primary endpoint, 4% missed it and 34% stopped early.

  • Completed, result not reported66159%
  • Status unknown13212%
  • Met its primary endpoint12411%
  • Ongoing12411%
  • Stopped: other or unclear424%
  • Stopped: sponsor or business decision101%
  • Stopped: enrollment or feasibility91%
  • Missed its primary endpoint71%
  • Stopped: lack of efficacy3<1%
  • Stopped: funding3<1%
  • Stopped: safety1<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.